| Keat-jin Lee, MD | |
|
1 Long Wharf Dr, Suite 302, New Haven, CT 06511-5991 | |
| (203) 777-4005 | |
| (203) 776-7741 |
| Full Name | Keat-jin Lee |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 1 Long Wharf Dr, New Haven, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891716502 | NPI | - | NPPES |
| 001152339 | Medicaid | CT | |
| 041069592 | Other | CT | RAILROAD MEDICARE PIN |
| Entity Name | Southern New England Ear, Nose, Throat And Facial Plastic Surgery Grou |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215164058 PECOS PAC ID: 3971655325 Enrollment ID: O20090715000326 |
News Archive
The Medical Research Council (MRC) has welcomed the Food Standards Agency's (FSA) decision to recommend the mandatory fortification of flour with folic acid.
The results for the fifth year of the European Research Council's funding programs show that LMU was again among the most successful competitors. Ten LMU researchers were awarded prestigious ERC grants, each worth around 2 million euros. Six of them received Advanced Investigator Grants and Starting Grants went to four others. The total amount of ERC funding acquired by applicants from LMU last year was approximately 19.5 million euros.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer formation, the immune system is forced to make a momentous decision. It either activates and suppresses tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow and making treatment more difficult. Because this tipping point occurs before a person even realizes something is wrong, doctors are unable to directly observe this critical stage.
ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the third quarter of 2009. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended October 3, 2009.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keat-jin Lee, MD 1 Long Wharf Dr, Suite 302, New Haven, CT 06511-5991 Ph: (203) 777-4005 | Keat-jin Lee, MD 1 Long Wharf Dr, Suite 302, New Haven, CT 06511-5991 Ph: (203) 777-4005 |
News Archive
The Medical Research Council (MRC) has welcomed the Food Standards Agency's (FSA) decision to recommend the mandatory fortification of flour with folic acid.
The results for the fifth year of the European Research Council's funding programs show that LMU was again among the most successful competitors. Ten LMU researchers were awarded prestigious ERC grants, each worth around 2 million euros. Six of them received Advanced Investigator Grants and Starting Grants went to four others. The total amount of ERC funding acquired by applicants from LMU last year was approximately 19.5 million euros.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
You think that your immune system is there to protect you. But what happens when it starts working against you? In the earliest stages of cancer formation, the immune system is forced to make a momentous decision. It either activates and suppresses tumor growth to help the body fight disease, or it becomes dysfunctional, helping the tumor grow and making treatment more difficult. Because this tipping point occurs before a person even realizes something is wrong, doctors are unable to directly observe this critical stage.
ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the third quarter of 2009. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended October 3, 2009.
› Verified 5 days ago
Dr. Kiley Edward Trott, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Park Street, Wing West Pavilion Fl 2nd Floor, New Haven, CT 06504 Phone: 203-785-5430 Fax: 203-785-3970 | |
Mark S Bianchi, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 55 Lock Street, New Haven, CT 06511 Phone: 203-375-0050 Fax: 203-380-1616 | |
Dr. Sara Isabel Pai, MD, PHD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 35 Park St, New Haven, CT 06519 Phone: 855-476-4569 | |
Dr. Richard Peter Manes, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave Fl 4, Yale Physicians Building, New Haven, CT 06519 Phone: 203-785-2593 Fax: 203-785-3970 | |
Sam D Schild, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 330 Cedar Street, New Haven, CT 06510 Phone: 203-785-5430 | |
Mark A Dagostino, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, Suite 302, New Haven, CT 06511 Phone: 203-776-1288 Fax: 203-776-7741 | |
Ken Yanagisawa, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, Suite 302, New Haven, CT 06511 Phone: 203-787-4244 Fax: 203-776-7741 |